| Followers | 1437 |
| Posts | 30112 |
| Boards Moderated | 23 |
| Alias Born | 12/10/2012 |
Tuesday, January 28, 2020 5:02:56 PM
$HEPA : CRV431 treats Liver Fibrosis
Here’s the best part of the Article.....
To date, we have evaluated dozens of investigational drugs from academia and industry, and CRV431 has been one of the most potent and consistent antifibrotic drug candidates that we've tested. Based on our findings, we believe that CRV431 shows strong potential for treating liver fibrosis."
GO $HEPA...... GO $CTRVW
Here’s the best part of the Article.....
To date, we have evaluated dozens of investigational drugs from academia and industry, and CRV431 has been one of the most potent and consistent antifibrotic drug candidates that we've tested. Based on our findings, we believe that CRV431 shows strong potential for treating liver fibrosis."
GO $HEPA...... GO $CTRVW
Recent HEPA News
- Hepion Pharmaceuticals In-Licenses ctRNA Biomarker Assay to Facilitate Early Diagnosis and Surveillance of Hepatocellular Carcinoma • GlobeNewswire Inc. • 03/03/2026 12:35:00 PM
- Hepion Pharmaceuticals Successfully Completes Application to the OTCQB • GlobeNewswire Inc. • 06/25/2025 12:30:00 PM
- Hepion Pharmaceuticals Announces Dr. Kaouthar Lbiati as Interim Chief Executive Officer • GlobeNewswire Inc. • 06/16/2025 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/12/2025 09:00:12 PM
- Hepion Pharmaceuticals Announces Receipt of Delisting Notification from Nasdaq • GlobeNewswire Inc. • 05/12/2025 08:30:00 PM
- Hepion Pharmaceuticals Executes Binding Letter of Intent with New Day Diagnostics to Commercialize Diagnostic Tests for Celiac Disease, Respiratory Multiplex, H. Pylori and HCC • GlobeNewswire Inc. • 05/07/2025 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2025 12:59:37 PM
- Form PRER14A - Preliminary Proxy Soliciting materials • Edgar (US Regulatory) • 04/23/2025 08:05:48 PM
